Wealthfront Advisers’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,662
Closed -$220K 792
2022
Q1
$220K Buy
+2,662
New +$220K ﹤0.01% 749
2021
Q4
Sell
-6,947
Closed -$807K 769
2021
Q3
$807K Buy
6,947
+3,948
+132% +$459K ﹤0.01% 497
2021
Q2
$665K Buy
+2,999
New +$665K ﹤0.01% 480